News: BioPharmX Corporation (NYSE: BPMX) Acne patients may soon have another option, which some doctors call the “holy grail” of acne care: a truly safe and effective topical therapy expecting to launch phase three clinical trials for BPX-01 soon. Their focus is to develop products that treat health or age-related conditions that are not presently being addressed, treated or are treated with less than the highest standard drug therapies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.